1. Yu, S., Fu, L., Lu, J., Wang, Z., & Fu, W. (2020). Xiao-Yao-San reduces blood-brain barrier injury induced by chronic stress in vitro and vivo via glucocorticoid receptor-mediated upregulation of Occludin. Journal of Ethnopharmacology, 246, 112–165.
2. Wei, Z. Z., Fang, X. Y., Fan, S. K., Peng, M. F., Bai, M., & Miao, M. S. (2019). Research progress on traditional Chinese medicine in preventing and treating cerebral ischemia injury based on “nose-brain” pathway. China Journal of Chinese Material Medicine, 44(22), 4800–4805. (Chinese).
3. Dong, Y., Di, L. Q., Zhao, X. L., Bi, X. L., Li, J. S., & Cai, B. C. (2019). Pharmaceutical research progress in the design of brain drug delivery system for intranasal administration. Chinese Pharmacological Journal, 21(3), 271–273. (Chinese).
4. Zhang, Q. L., Fu, B. M., & Zhang, Z. J. (2017). Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability. Drug Delivery, 24(1), 1037–1044.
5. Dufès, C., Al Robaian, M., & Somani, S. (2013). Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. Drug Delivery and Translational Research, 4(5), 629–640.